Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants. (journals.asm.org)

Authors: Morita J … Uchida N Journal: Antimicrobial Agents and Chemotherapy Published: 2026-05-06 DOI: https://doi.org/10.1128/aac.01770-25